# The Ideal Second-Line Treatment Options for Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine-Based First-Line Chemotherapy: A Result From Bayesian Network-Meta Analysis
> Syarifuddin E.

URL kanonis: https://discover.unhas.ac.id/publications/the-ideal-second-line-treatment-options-for-patients-with-advanced-biliary-tract
Jurnal / Konferensi: Asian Pacific Journal of Cancer Prevention
Tahun terbit: 2025
DOI: https://doi.org/10.31557/APJCP.2025.26.8.2777
ISSN: 15137368
Kuartil SJR: Q2
Citations: 0

## Authors
- Syarifuddin E.

## Abstract
The combination of oral capecitabine with varlitinib could be a promising second-line treatment for patients with advanced biliary tract cancer refractory to gemcitabine-based first-line regimen.

## Keywords
- Gemcitabine
- Biliary tract cancer
- Refractory (planetary science)
- Medicine
- Line (geometry)
- Second line treatment
- Chemotherapy
- Oncology
- Biliary tract
- Meta-analysis
- Ideal (ethics)
- Internal medicine
- Mathematics
- Physics
- Astrobiology
- Philosophy
- Geometry
- Epistemology

---
Sumber: Discover Unhas — RIMS Universitas Hasanuddin.
Saat mengutip, gunakan DOI bila tersedia atau URL kanonis di atas.